Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/2U3 stock hub

ETR/2U3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/2U3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

26.2B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/2U3

In the news

Latest news · ETR/2U3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.9

P25 12.3P50 15.7P75 20.2

Trailing P/E36.9

P25 16.4P50 20.9P75 30.4

ROE3.7

P25 -6.7P50 8.5P75 17.2

ROIC4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/2U3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees Change	343%
Employees Change Percent	1.34
Enterprise value	EUR 29.4B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CH0432492467
Last refreshed	2026-05-10
Market cap	EUR 26.2B
Price	EUR 53.42
Price currency	EUR
Rev Per Employee	368,914.73x
Sector	Healthcare
Sic	3851
Symbol	etr/2U3

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.71%
EV Earnings	41.34x
EV/EBIT	27.21x
EV/EBITDA	14.25x
EV/FCF	19.58x
EV/Sales	3.15x
FCF yield	5.72%
Forward P/E	16.88x
P/B ratio	1.37x
P/E ratio	36.89x
P/S ratio	2.84x
PE Ratio3 Y	50.12x
PE Ratio5 Y	71.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.63%
EBITDA Margin	21.3%
FCF margin	16.26%
Gross margin	55.78%
Gross Profit	EUR 5.1B
Gross Profit Growth	7.54%
Gross Profit Growth Q	10.27%
Gross Profit Growth3 Y	6.59%
Gross Profit Growth5 Y	12.78%
Net Income	EUR 710.3M
Net Income Growth	-26.88%
Net Income Growth Q	-46%
Net Income Growth3 Y	33.92%
Pretax Margin	9.27%
Profit Margin	7.7%
Profit Per Employee	EUR 28,413
ROA	2.47
Roa5y	2.31
ROCE	4.32
ROE	3.71
Roe5y	3.57
ROIC	4
Roic5y	3.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.97%
Div CAGR3	13.33%
EPS Growth	-25.9
EPS Growth Q	-44.58
EPS Growth3 Y	34.16
FCF Growth	4.6%
FCF Growth Q	0.36%
FCF Growth3 Y	42.15%
FCF Growth5 Y	30.78%
OCF Growth	8.73%
OCF Growth Q	8.85%
OCF Growth10 Y	1.06%
OCF Growth3 Y	23.09%
OCF Growth5 Y	19.42%
Revenue Growth	7.14x
Revenue Growth Q	9.42x
Revenue Growth3 Y	6.19x
Revenue Growth5 Y	8.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.34
Assets	EUR 27.4B
Cash	EUR 1.4B
Current Assets	EUR 5.6B
Current Liabilities	EUR 2.5B
Debt	EUR 4.6B
Debt EBITDA	EUR 2.23
Debt Equity	EUR 0.24
Debt FCF	EUR 3.04
Equity	EUR 19.2B
Interest Coverage	5.98
Liabilities	EUR 8.2B
Long Term Assets	EUR 21.8B
Long Term Liabilities	EUR 5.7B
Net Cash	EUR -3.1B
Net Cash By Market Cap	EUR -11.93
Net Debt EBITDA	EUR 1.59
Net Debt Equity	EUR 0.16
Net Debt FCF	EUR 2.08
Tangible Book Value	EUR 3.5B
Tangible Book Value Per Share	EUR 7.11
WACC	7.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.2
Inventory Turnover	1.97
Net Working Capital	EUR 2.3B
Quick ratio	1.22
Working Capital	EUR 3.1B
Working Capital Turnover	EUR 2.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.72%
Dividend Growth	2.23%
Dividend Growth Years	5%
Dividend per share	EUR 0.31
Dividend Years	6
Dividend Yield	0.49%
Ex Div Date	2026-05-05
Last Dividend	EUR 0.31
Payout Frequency	Annual
Payout Ratio	20.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.95%
200-day SMA	67.66
50-day SMA	66.37
50-day SMA vs 200-day SMA	50under200
All Time High	85.94
All Time High Change	-37.84%
All Time High Date	2025-05-12
All Time Low	53.42
All Time Low Change	0%
All Time Low Date	2026-05-08
ATR	1.67
Beta	0.7
Ch YTD	-21.81
High	55.26
High52	85.94
High52 Date	2025-05-12
High52ch	-37.84%
Low	53.42
Low52	53.42
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-19.51%
Price vs 200-day SMA	-21.04%
RSI	20.76
RSI Monthly	0
RSI Weekly	31.17
Sharpe ratio	-1.57x
Sortino ratio	-1.75
Total Return	1.21%
Tr YTD	-21.43
Tr1m	-16.26%
Tr1w	-15.84%
Tr3m	-18.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.1B
Operating Income Growth	-6.92
Operating Income Growth Q	-11.25
Operating Income Growth3 Y	11.68
Operating margin	11.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	486,373,670%
Net Borrowing	-80,556,390
Shares Insiders	0.17%
Shares Institutions	58.71%
Shares Qo Q	-0.43%
Shares Yo Y	-0.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.4B
Average Volume	1,211.6x
Bv Per Share	39.36
CAPEX	EUR -499.6M
Ch1m	-16.66
Ch1w	-16.24
Ch1y	-36.48
Ch3m	-19.31
Ch6m	-15.63
Change	-3.36%
Change From Open	-3.19
Close	55.28
Days Gap	-0.18
Depreciation Amortization	871,704,936
Dollar Volume	88,944.3
Earnings Date	2026-05-06
EBIT	EUR 1.1B
EBITDA	EUR 2B
EPS	EUR 1.45
F Score	7
FCF	EUR 1.5B
FCF EV Yield	5.11x
Financing CF	-1,002,598,800
Fiscal Year End	December
Founded	1,945
Goodwill	7,850,432,196
Graham Number	35.70888
Graham Upside	-33.15
Income Tax	EUR 144.8M
Investing CF	-853,423,200
Is Primary Listing	0
Last Earnings Date	2026-02-25
Last Report Date	2026-03-31
Lynch Fair Value	EUR 36.2
Lynch Upside	-32.23
Ma150	66.66
Ma150ch	-19.86%
Ma20	64.31
Ma20ch	-16.93%
Net CF	143,971,800
Open	55.18
P FCF Ratio	17.47
P OCF Ratio	13.11
Payment Date	2026-05-07
Position In Range	0
Ppne	4,428,905,526
Price Date	2026-05-08
Price EBITDA	EUR 13.34
Ptbv Ratio	7.56
Relative Volume	1.37x
Revenue	9,222,868,200x
SBC By Revenue	1.58x
Share Based Comp	145,706,400
Tax By Revenue	1.57x
Tax Rate	16.94%
Tr6m	-15.23%
Volume	1,665

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/2U3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.31 annual per share

Payout ratio

+20.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

5 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2026-05-05

Performance

ETR/2U3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/2U3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.7%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.7%

Negative means the company is buying back shares.

Technical

ETR/2U3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

20.8

Below 30: short-term oversold

Price vs 200-day MA

-21.0%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

-1.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/2U3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/2U3 stock rating?

etr/2U3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/2U3 analysis?

The full report lives at /stocks/etr/2U3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/2U3?

The latest report frames etr/2U3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/2U3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.